Aardvark Therapeutics is a biopharmaceutical company focused on small molecule therapies for the treatment of obesity and metabolic diseases. Aardvark’s lead product (BitteraTM) is a first-in-class oral drug that disrupts hunger signalling and regulates energy homeostasis
Location: United States, California, San Diego
Employees: 11-50
Total raised: $29M
Founded date: 2017
Investors 2
| Date | Name | Website |
| - | Vickers Ve... | vickersven... |
| 20.06.2023 | Premier Pa... | premierpar... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 05.08.2021 | Series B | $29M | - |
Mentions in press and media 2
| Date | Title | Description | Source |
| 06.08.2021 | Aardvark Therapeutics Closes $29M Series B Funding | Aardvark Therapeutics, Inc., a San Diego, CA-based clinical stage biopharmaceutical company, complet... | finsmes.co... |
| 05.08.2021 | Aardvark Therapeutics Gets $29M In Series B | San Diego-based Aardvark Therapeutics, a biopharmaceuticals company focused on metabolic diseases, s... | socaltech.... |